Sanofi Sues HHS, HRSA for Contract Details Between Covered Entities, Pharmacies

Drug manufacturer Sanofi has sued the federal government for information about contracts between covered entities and contract pharmacies.
French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Range of Motives Likely Behind Surge in Drugmaker Contract Pharmacy Changes, Say Provider Advisers

Jason Reddish, a principal at Powers Law who represents covered entities, said drugmakers were "emboldened" by recent federal court decisions to issue contract pharmacy restrictions.
A surge of recent drug manufacturer contract pharmacy policy changes may be driven by recent legal developments, new state laws, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Alkermes Is 36th Drugmaker to Implement Contract Pharmacy Restrictions, Sanofi Tightens Policy

Pharmaceutical manufacturer Alkermes is the 36th drugmaker to implement 340B contract pharmacy restrictions.
Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Reform Could Generate Federal Savings, Says Consulting Firm That Has Conducted 340B Studies for Pharma Friendly Groups

Avalere's Milena Sullivan told 340B Report that it's important to understand "the impact 340B reform could have on federal spending."
A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Manufacturers Announce Refunds to 340B Providers

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Is Seventh State to Enact 340B Contract Pharmacy Law, State Also Expands Covered Entity Reporting

Minnesota Gov. Tim Walz (D) signed a law to prohibit drugmaker 340B contract pharmacy restrictions in the state.
Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Follows PhRMA in Seeking to Block Mississippi 340B Contract Pharmacy Law

Drugmaker Novartis has filed the second lawsuit challenging Mississippi's 340B contract pharmacy access law.
Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BMS Requires Re-Designation of 340B Contract Pharmacies and New Requirements Intended to Prevent Alternative Distribution Models

Drug manufacturer BMS updated its 340B contract pharmacy restrictions to require pharmacies to re-register by June 21 and add additional requirements.
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Vertex is First to Offer Contract Pharmacy Policy Exemptions to Several States; GSK Restores Discounts To WV Providers

Drugmaker Vertex implemented 340B contract pharmacy restrictions but exempted the six states with laws prohibiting such policies.
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

UCB is 26th Drugmaker to Exempt Arkansas Providers from Contract Pharmacy Restrictions

UCB exterior sign and building
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions.
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live